We are live on ! Find out more
SP

Symmetry Partners Portfolio holdings

AUM $1.96B
1-Year Est. Return 19.83%
This Fund
S&P 500
This Quarter Est. Return
-3.27%
1 Year Est. Return
+19.83%
3 Year Est. Return
+58.53%
5 Year Est. Return
+62.51%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$18.4M
Cap. Flow
+$84.8M
Cap. Flow %
5.33%
Top 10 Hldgs %
33.4%
Holding
616
New
13
Increased
89
Reduced
73
Closed
45

Sector Composition

Rank Sector Weight
1 Technology 8.36%
2 Financials 5.72%
3 Healthcare 4.65%
4 Industrials 4.08%
5 Consumer Discretionary 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
X
601
DELISTED
US Steel
X
-17,269
Closed -$411K
DAY
602
DELISTED
Dayforce
DAY
-2,202
Closed -$230K
QVCGA
603
DELISTED
QVC Group Inc Series A
QVCGA
-236
Closed -$90K
LSXMK
604
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
-5,644
Closed -$222K
ABMD
605
DELISTED
Abiomed Inc
ABMD
-603
Closed -$217K
AVLR
606
DELISTED
Avalara, Inc.
AVLR
-3,403
Closed -$439K
INFO
607
DELISTED
IHS Markit Ltd. Common Shares
INFO
-4,558
Closed -$606K
XLNX
608
DELISTED
Xilinx Inc
XLNX
-3,300
Closed -$700K
FM
609
DELISTED
iShares Frontier and Select EM ETF
FM
-117,177
Closed -$4.04M

Similar funds

Symmetry Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Symmetry Partners held 616 positions worth $1.59B, up 1.2% from $1.57B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Symmetry Partners deployed $84.8M of net new capital in Q1 2022, opening 13 new positions and adding to 89 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Aggregate Bond ETF: 1,213,000 shares worth $61.3M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $3.51M trimmed.

  • Symmetry Partners's largest Q1 2022 buy was JPMorgan BetaBuilders US Aggregate Bond ETF: 1,213,000 shares worth $61.3M.
  • Symmetry Partners added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $11.6M increase.
  • Symmetry Partners's biggest Q1 2022 reduction was Pfizer, cutting an estimated $3.51M.
  • Symmetry Partners fully exited Vanguard Morningstar Mid-Cap Value ETF in Q1 2022, selling an estimated $21.3M.
  • Symmetry Partners's ten largest holdings make up 33% of its $1.59B portfolio in Q1 2022.
  • Symmetry Partners opened 13 new positions and closed 45 in Q1 2022.
  • Symmetry Partners's portfolio value rose 1.2% quarter-over-quarter to $1.59B.

Based on Symmetry Partners's 13F filing for Q1 2022, filed 4 Apr 2022.